RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ODANACATIB (MK-822) IN THE TREATMENT OF POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY: RESULTS AT 24 MONTHS

被引：0
|
作者：
Roux, C. [1 ]
Santora, A. [2 ]
Eisman, J. [3 ]
Bone, H. [4 ]
McClung, M. [5 ]
Recker, R. [6 ]
Verbruggen, N. [7 ]
Hustad, C. [2 ]
Dasilva, C. [2 ]
Kimmel, D.
机构：
[1] Univ Paris, Cochin Hosp, F-75252 Paris, France
[2] Merck Res Labs, Rahway, NJ USA
[3] St Vincents Hosp, Garvan Inst Med Res, Sydney, NSW 2010, Australia
[4] Michigan Bone & Mineral Ctr, Detroit, MI USA
[5] Oregon Osteoporosis Ctr, Portland, OR USA
[6] Creighton Univ, Sch Med, Omaha, NE USA
[7] Merck Res Labs, Brussels, Belgium
来源：
OSTEOPOROSIS INTERNATIONAL | 2009年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] A Randomized, Double-Blind, Placebo-Controlled Study of Odanacatib (MK-822) in the Treatment of Postmenopausal Women with Low Bone Mineral Density: 24-Month Results
    McClung, M.
    Bone, H.
    Cosman, F.
    Roux, C.
    Verbruggen, N.
    Hustad, C.
    DaSilva, C.
    Santora, A.
    Ince, A.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S82 - S82
  • [2] Two year results in a randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in postmenopausal women with low bone mineral density
    Eisman, J. A.
    Recker, R. R.
    McClung, M.
    Bone, H.
    Roux, C.
    Verbruggen, N.
    Hustad, C. M.
    DaSilva, C.
    Santora, A.
    Ince, A.
    BONE, 2009, 44 : S103 - S104
  • [3] TWO YEAR RESULTS IN A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF ODANACATIB (MK-822) IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Eisman, J. A.
    Recker, R. R.
    Kimmel, D.
    McClung, M.
    Bone, H.
    Roux, C.
    Verbruggen, N.
    Hustad, C.
    DaSilva, C.
    Santora, A.
    Ince, A.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (01) : 167 - 168
  • [4] A randomized, double-blind, placebo-controlled study of odanacatib (MK-822) in the treatment of postmenopausal women with low bmd: 18-month results
    McClung, M.
    Bone, H.
    Verbruggen, N.
    Rybak-Feiglin, A.
    daSilva, C.
    Santora, A.
    Ince, A.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S53 - S53
  • [5] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, STUDY OF CLASSIC YIN AND YANG TONIC FORMULA FOR POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
    Tang, D.
    Li, C.
    Xuejun, C.
    Yang, F.
    Shi, Q.
    Wang, Y.
    OSTEOPOROSIS INTERNATIONAL, 2013, 24 : S609 - S609
  • [6] A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Alendronate on Bone Mineral Density and Bone Remodelling in Perimenopausal Women With Low Bone Mineral Density
    Khan, Aliya
    Dubois, Sacha
    Khan, Amina A.
    Rahman, Zohair
    Khan, O. Ahmed
    Syed, Hamid T.
    Derzko, Christine
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2014, 36 (11) : 976 - 982
  • [7] Odanacatib treatment in postmenopausal women with low bone mineral density: 24-month results
    McClung, M.
    Eisman, J. A.
    Bone, H. G.
    Roux, C.
    Recker, R. R.
    Verbruggen, N.
    Hustad, C. M.
    daSilva, C.
    Kimmel, D.
    Santora, A.
    Ince, A.
    BONE, 2009, 44 (02) : S438 - S438
  • [8] Effects of 24 Months of Treatment With Romosozumab Followed by 12 Months of Denosumab or Placebo in Postmenopausal Women With Low Bone Mineral Density: A Randomized, Double-Blind, Phase 2, Parallel Group Study
    McClung, Michael R.
    Brown, Jacques P.
    Diez-Perez, Adolfo
    Resch, Heinrich
    Caminis, John
    Meisner, Paul
    Bolognese, Michael A.
    Goemaere, Stefan
    Bone, Henry G.
    Zanchetta, Jose R.
    Maddox, Judy
    Bray, Sarah
    Grauer, Andreas
    JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (08) : 1397 - 1406
  • [9] Effects of bendroflumethiazide on bone mineral density; results from the BONATHIAD randomized double-blind placebo-controlled cohort study
    Emmanuel, Thomas
    Kruse, Christian
    Leere, Julius Simoni
    Poulsen, Trine Holmgaard
    Vestergaard, Peter
    BONE REPORTS, 2020, 13
  • [10] A double-blind, placebo-controlled, phase III Study of bazedoxifene/conjugated estrogens in postmenopausal women: Effects on bone mineral density
    Lindsay, R.
    Ronkin, S.
    Constantine, G.
    Olivier, S.
    Pickar, J.
    BONE, 2009, 44 : S37 - S37
12345